These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 17697536)
1. Enzyme replacement therapy in patients with Fabry's disease. Tsuboi K J Int Med Res; 2007; 35(4):574-81. PubMed ID: 17697536 [TBL] [Abstract][Full Text] [Related]
2. Enzyme replacement therapy in Fabry's disease: recent advances and clinical applications. Mignani R; Cagnoli L J Nephrol; 2004; 17(3):354-63. PubMed ID: 15365954 [TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of recombinant human alpha-galactosidase A replacement therapy in Fabry's disease. Eng CM; Guffon N; Wilcox WR; Germain DP; Lee P; Waldek S; Caplan L; Linthorst GE; Desnick RJ; N Engl J Med; 2001 Jul; 345(1):9-16. PubMed ID: 11439963 [TBL] [Abstract][Full Text] [Related]
4. [Anderson-Fabry's disease: diagnostic problems, therapeutic relevance, and clinical experience in the treatment of the disease with enzyme replacement therapy in nephropathic patients]. Cianciaruso B; Pisani A; Andreucci MV; Parente N; Andria G; Federico S; Sabbatini M; Sessa A G Ital Nefrol; 2003; 20(2):113-9. PubMed ID: 12746795 [TBL] [Abstract][Full Text] [Related]
5. Identification of Fabry's disease by the screening of alpha-galactosidase A activity in male and female hemodialysis patients. Tanaka M; Ohashi T; Kobayashi M; Eto Y; Miyamura N; Nishida K; Araki E; Itoh K; Matsushita K; Hara M; Kuwahara K; Nakano T; Yasumoto N; Nonoguchi H; Tomita K Clin Nephrol; 2005 Oct; 64(4):281-7. PubMed ID: 16240899 [TBL] [Abstract][Full Text] [Related]
6. [Ocular findings in Fabry's disease]. Kuzman T; Juri J; Mrsić M; Jeren-Strujić B; Mandić Z; Sikić J Acta Med Croatica; 2006; 60(2):163-6. PubMed ID: 16848212 [TBL] [Abstract][Full Text] [Related]
7. An atypical variant of Fabry's disease in men with left ventricular hypertrophy. Nakao S; Takenaka T; Maeda M; Kodama C; Tanaka A; Tahara M; Yoshida A; Kuriyama M; Hayashibe H; Sakuraba H N Engl J Med; 1995 Aug; 333(5):288-93. PubMed ID: 7596372 [TBL] [Abstract][Full Text] [Related]
8. A systematic review of the clinical effectiveness and cost-effectiveness of enzyme replacement therapies for Fabry's disease and mucopolysaccharidosis type 1. Connock M; Juarez-Garcia A; Frew E; Mans A; Dretzke J; Fry-Smith A; Moore D Health Technol Assess; 2006 Jun; 10(20):iii-iv, ix-113. PubMed ID: 16729919 [TBL] [Abstract][Full Text] [Related]
9. Decline of plasma brain natriuretic peptide during enzyme replacement therapy in a female patient with heterozygous Fabry's disease. Masugata H; Senda S; Goda F; Yamagami A; Okuyama H; Kohno T; Hosomi N; Yukiiri K; Noma T; Murao K; Kohno M; Itoh S Tohoku J Exp Med; 2009 Mar; 217(3):169-74. PubMed ID: 19282651 [TBL] [Abstract][Full Text] [Related]
10. Screening Fabry's disease in chronic kidney disease patients not on dialysis: a multicenter study. Yeniçerioğlu Y; Akdam H; Dursun B; Alp A; Sağlam Eyiler F; Akın D; Gün Y; Hüddam B; Batmazoğlu M; Gibyeli Genek D; Pirinççi S; Ersoy İR; Üzüm A; Soypaçacı Z; Tanrısev M; Çolak H; Demiral Sezer S; Bozkurt G; Akyıldız UO; Akyüz Ünsal Aİ; Ünübol M; Uslu M; Eryılmaz U; Günel C; Meteoğlu İ; Yavaşoğlu İ; Ünsal A; Akar H; Okyay P Ren Fail; 2017 Nov; 39(1):104-111. PubMed ID: 27832731 [TBL] [Abstract][Full Text] [Related]
11. Genetics and Gene Therapy of Anderson-Fabry Disease. Simonetta I; Tuttolomondo A; Di Chiara T; Miceli S; Vogiatzis D; Corpora F; Pinto A Curr Gene Ther; 2018; 18(2):96-106. PubMed ID: 29618309 [TBL] [Abstract][Full Text] [Related]
12. [Enzyme replacement therapy in Fabry's disease]. Alvarez L; del Pozo C; Trigueros M; Sánchez L; Albero MD; López-Menchero R; Ortega E Nefrologia; 2005; 25(3):322-7. PubMed ID: 16053014 [TBL] [Abstract][Full Text] [Related]
13. [Efficacy of replacement enzyme therapy on central nervous system manifestations in Fabry's disease]. Besson G; Vadot W; Guellerin J Rev Med Interne; 2010 Dec; 31 Suppl 2():S257-9. PubMed ID: 21211675 [TBL] [Abstract][Full Text] [Related]
14. Megadolichobasilar anomaly with thrombosis in a family with Fabry's disease and a novel mutation in the alpha-galactosidase A gene. Garzuly F; Maródi L; Erdös M; Grubits J; Varga Z; Gelpi E; Rohonyi B; Mázló M; Molnár A; Budka H Brain; 2005 Sep; 128(Pt 9):2078-83. PubMed ID: 15947062 [TBL] [Abstract][Full Text] [Related]
15. [Effect of enzyme replacement therapy (ERT) on renal function of patients with Fabry's disease]. Thomaidis T; Relle M; Reinke J; Beck M; Schwarting A Med Klin (Munich); 2009 Sep; 104(9):699-703. PubMed ID: 19779674 [TBL] [Abstract][Full Text] [Related]
16. [Intravenous enzyme substitution therapy in children with Fabry's disease]. Tøndel C; Laegreid LM; Hirth A; Houge G; Månsson JE; Søvik O Tidsskr Nor Laegeforen; 2003 Dec; 123(23):3388-90. PubMed ID: 14713976 [TBL] [Abstract][Full Text] [Related]
17. Fabry's disease--a comprehensive review on pathogenesis, diagnosis and treatment. Mahmud HM J Pak Med Assoc; 2014 Feb; 64(2):189-94. PubMed ID: 24640811 [TBL] [Abstract][Full Text] [Related]
18. Impact of enzyme replacement therapy on cardiac morphology and function and late enhancement in Fabry's cardiomyopathy. Lui CY; Ju H Am J Cardiol; 2006 Dec; 98(11):1557-8. PubMed ID: 17126672 [No Abstract] [Full Text] [Related]
19. [Fabry's disease: a comparison of the effectiveness of two different enzyme replacement therapies]. Pisani A; Visciano B; Capuano I; Mancini A; Riccio E G Ital Nefrol; 2013; 30(1):. PubMed ID: 23832445 [TBL] [Abstract][Full Text] [Related]
20. [Renal involvement in Fabry's disease: diagnosis, follow-up and enzyme replacement therapy]. Mignani R; Feriozzi S; Carraro G; Martinelli F; Cianciaruso B G Ital Nefrol; 2009; 26(5):577-84. PubMed ID: 19802803 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]